Skip to main content
Cyber Week Sale - Get 40% off Vantage
Published loading...Updated

Weight-loss drug overpriced for public patients

Summary by RTÉ
A new study for the HSE has found that making the weight loss drug Mounjaro available to public patients would not be value for money at the current price.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

RTÉ broke the news in Ireland on Thursday, December 4, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal